These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9739409)

  • 1. MIB-1 immunohistometry on Tru-cut biopsies in inflammatory and cirrhotic liver disease.
    Biesterfeld S; Hoffmann E
    Anal Quant Cytol Histol; 1998 Aug; 20(4):268-74. PubMed ID: 9739409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MIB-1 immunohistometry of follicular adenoma and follicular carcinoma of the thyroid gland.
    Rickert D; Mittermayer C; Lindenfelser R; Biesterfeld S
    Anal Quant Cytol Histol; 2000 Jun; 22(3):229-34. PubMed ID: 10872040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited value of PCNA immunohistometry on tru-cut biopsies in inflammatory and cirrhotic liver disease.
    Biesterfeld S; Kebernik M
    Anal Quant Cytol Histol; 2001 Dec; 23(6):433-4. PubMed ID: 11777279
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential diagnosis of keratoacanthoma and squamous cell carcinoma of the epidermis by MIB-1 immunohistometry.
    Biesterfeld S; Josef J
    Anticancer Res; 2002; 22(5):3019-23. PubMed ID: 12530035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TV-image analysis based quantification of the proliferative activity and the apoptotic rate in thyroid tumors and thyroiditis.
    Biesterfeld S; Rickert D; Eichler S; Fürste K; Mrusek S; Alfer J
    Anticancer Res; 2003; 23(5b):4269-75. PubMed ID: 14666637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and prognostically valid quantification of immunohistochemical reactions by immunohistometry of the most positive tumour focus. A prospective follow-up study on breast cancer using antibodies against MIB-1, PCNA, ER, and PR.
    Biesterfeld S; Klüppel D; Koch R; Schneider S; Steinhagen G; Mihalcea AM; Schröder W
    J Pathol; 1998 May; 185(1):25-31. PubMed ID: 9713356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytometric measurement of cell proliferation in echo-guided biopsies from focal lesions of the liver.
    Faccioli S; Chieco P; Gramantieri L; Stecca BA; Bolondi L
    Mod Pathol; 1996 Feb; 9(2):120-5. PubMed ID: 8657717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical evidence for the expression of proliferating cell nuclear antigen (PCNA) by non-proliferating hepatocytes adjacent to metastatic tumours and in inflammatory conditions.
    Harrison RF; Reynolds GM; Rowlands DC
    J Pathol; 1993 Oct; 171(2):115-22. PubMed ID: 7904308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image cytometric comparison of proliferating cell nuclear antigen and MIB-1 staining in hepatocellular carcinoma and adjacent liver tissue.
    Wells SJ; DeRose PB; Cohen C
    Cytometry; 1996 Sep; 26(3):198-203. PubMed ID: 8889391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of Ki-67 in liver biopsy specimens using monoclonal antibody to Mib-1].
    Matsumoto K; Tanimoto K; Michitaka K; Furutani T; Nakaya M; Horiike N; Onji M
    Rinsho Byori; 1999 Oct; 47(10):956-60. PubMed ID: 10590670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sampling variability on percutaneous liver biopsy.
    Abdi W; Millan JC; Mezey E
    Arch Intern Med; 1979 Jun; 139(6):667-9. PubMed ID: 443970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative prognostic value of Ki-67 and MIB-1 proliferation indices in breast cancer.
    Veronese SM; Maisano C; Scibilia J
    Anticancer Res; 1995; 15(6B):2717-22. PubMed ID: 8669852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1.
    Masood S; Bui MM; Lu L
    Ann Clin Lab Sci; 1998; 28(6):315-23. PubMed ID: 9846198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
    Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D
    Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
    El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
    APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical characteristics of hepatocellular carcinoma in non-cirrhotic livers.
    Witjes CD; ten Kate FJ; Verhoef C; de Man RA; IJzermans JN
    J Clin Pathol; 2013 Aug; 66(8):687-91. PubMed ID: 23585667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of pi class glutathione S-transferase and alpha-fetoprotein in hepatocellular carcinoma and chronic liver disease.
    Yusof YA; Yan KL; Hussain SN
    Anal Quant Cytol Histol; 2003 Dec; 25(6):332-8. PubMed ID: 14714299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative image analysis of MIB-1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast.
    Ostrowski ML; Chakraborty S; Laucirica R; Brown RW; Greenberg SD
    Anal Quant Cytol Histol; 1995 Feb; 17(1):15-24. PubMed ID: 7766265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of double staining of MIB-1 and AgNORs in primary breast carcinoma.
    Kidogawa H; Nanashima A; Yano H; Matsumoto M; Yasutake T; Nagayasu T
    Anticancer Res; 2005; 25(6B):3957-62. PubMed ID: 16309183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.